期刊文献+

uPA-siRNA重组慢病毒载体感染兔软骨细胞对uPA和MMP-3表达的影响 被引量:1

Effect of expression of uPA and MMP-3 in rabbit chondrocyte mediated by uPA-siRNA lentiviral vector
下载PDF
导出
摘要 目的靶向特异尿激酶型纤溶酶原激活物(uPA)-siRNA慢病毒表达载体并加载绿色荧光蛋白(GFP)后转染软骨细胞,观察其对软骨细胞表达uPA和基质金属蛋白酶3(MMP-3)的影响。方法培养软骨细胞并根据实验分为实验组(转染uPAsiRNA慢病毒载体)、空载体组(转染空慢病毒载体)、空白对照组(未进行任何处理)和TIMP组(加载MMP特异性抑制剂TIMP)。实验组:uPA-siRNA序列经慢病毒包装并加载GFP,通过Lipofectamine 2000转染入兔软骨细胞;空载体组:将慢病毒载体通过Lipofectamine 2000转染入兔软骨细胞;空白对照组正常培养软骨细胞;药物对照组:培养基中加特异性MMP抑制剂。所有细胞培养96h后应用逆转录-聚合酶链反应(RT-PCR)和蛋白免疫印迹法(Western blot)法分别检测软骨细胞uPA mRNA、MMP-3mRNA和蛋白的表达水平。结果慢病毒载体可成功转染到原代软骨细胞中,在感染复数(MOI)为100时转染率达到85%以上。实验组uPA mRNA、uPA蛋白和MMP-3mRNA及MMP-3蛋白的表达水平显著低于空载体组和空白对照组(P<0.01),而与药物干预组差异无统计学意义(P>0.05)。结论 uPA-siRNA慢病毒载体负载GFP可稳定转染软骨细胞并高效抑制uPA基因、蛋白表达,同时对MMP-3基因、蛋白表达也呈现高效抑制作用。抑制uPA的水平可降低显著MMP-3表达。 Objective To construct recombinant lentiviral vector carrying small interfering RNA against uPA gene with express‐ing reporter gene GFP ,and to observe its effect on the expression of uPA and MMP‐3 in chondrocytes .Methods siRNAs against uPA mRNA were designed and chemically synthesized .Recombinant lentiviral vector with uPA‐siRNA and reporter gene GFP was constructed .Rabbit chondrocytes were cultured and randomized into four groups :for uPA‐siRNA transfection group :recombinant lentiviral vector with uPA‐siRNA and GFP gene was transfected into chondrocytes using lipofectamine 2000 ;for empty vector transfection group :empty lentiviral vector was transfected into chondrocytes ;for non transfection group :chondrocytes were cul‐tured without any treatment ;for MMP inhibitor group :chondrocytes were cultured with MMP inhibitor TIMP .The mRNA and protein expression levels of uPA and MMP‐3 of chondrocytes were determined by RT‐PCR and Western blot after 96 h of treatment in all groups respectively .Results Recombinant lentiviral vector carrying uPA‐siRNA and reporter gene GFP was constructed and transfected into primary chondrocytes successfully .The transfection efficiency was more than 85% when multiplicity of infection (MOI) was 100 .The mRNA and protein expression levels of uPA were significantly decreased in uPA‐siRNA transfection group compared to three other groups(P〈0 .01) .MMP‐3 mRNA and protein levels were also down‐regulated in uPA‐siRNA transfection group compared to empty‐vector group and non‐transfection group(P〈0 .01) .However ,only decreased mRNA level of MMP‐3 was obtaind when compare uPA‐siRNA transfection group to MMP inhibitor group (P〈0 .01) .There was no significant difference of MMP‐3 protein level between uPA‐siRNA transfection group and MMP inhibitor group(P〉0 .05) .Conclusion Recombinant lenti‐viral vector carrying uPA‐siRNA and GFP gene can transfect primary chondrocytes successfully and inhibit uPA gene expression and protein level as well as MMP‐3 in chondrocytes efficiently .Low level of uPA could down regulate the expression of MMP‐3 .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第15期1892-1895,共4页 Chongqing medicine
基金 国家自然科学基金资助项目(30960387 81260453) 兵团医药卫生专项基金(2013BA020) 兵团国际交流合作基金(2011BC004 2012BC002)
关键词 RNA 小分子干扰 慢病毒载体 软骨细胞 尿激酶型纤溶酶原激活物 基质金属蛋白酶3 RNA, small interfering lentiviral vector chondrocytes urinary plasminogen activator matrix metall oproteinase 3
  • 相关文献

参考文献15

  • 1Hochberg MC. Osteoarthritis year 2012 in review: clinical [J]. Osteoarthritis Cartilage,2012,20(12) . 1465-1469.
  • 2Loeser RF. Aging processes and the development of oste- oarthritis[J]. Curt Opin Rheumatol, 2013, 25 ( 1 ) : 108- 113.
  • 3Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis[J]. Arthritis Res Ther, 2009,11 (3) : 227-231.
  • 4Gepstein A, Arbel G, Blumenfeld I, et al. Association of metalloproteinases, tissue inhibitors of matrix metallopro- teinases, and proteoglyeans with development, aging, and osteoarthritis processes in mouse temporomandibular joint [J]. Histochem Cell Biol, 2003,120(1) : 23-32.
  • 5Inuzuka K, Ogata Y, Nagase H, et al. Significance of coex- pression of urokinase-type plasminogen activator,and ma- trix metalloproteinase 3 (stromelysin) and 9(gelatinase B) in colorectal carcinoma[J]. J Surg Res, 2000,93 ( 2 ) : 211- 218.
  • 6Ramos-DeSimone N, Hahn-Dantona E, Sipley J, et al. Ac- tivation of matrix metalloproteinase-9(MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion [J]. J Biol Chern, 1999, 274 (19) : 13066- 13076.
  • 7Dreier R,Grassel S, Fuchs S, et al. Pro-MMP-9 is a spe- cific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cas- cade[J]. Exp Cell Res,2004,297(2) :303-312.
  • 8Murphy G, Atkinson S, Ward R, et al. The role of plas- minogen activators in the regulation of connective tissue metalloproteinases[J]. Ann N Y Acad Sci, 1992,667: 1- 12.
  • 9Massicotte F,Lajeunesse D,Benderdour M, et al. Can al- tered production of interleukin-lbeta, interleukin-6, trans- forming growth factor-beta and prostaglandin E(2) by isolated human suhchondral osteoblasts identify two sub- groups of osteoarthritic patients[J]. Osteoarthritis Carti- lage, 2002,10(6) : 491-500.
  • 10Sato T,Tamai H, Kobayashi M, et al. Immunohistochemi- cal properties in the patients with Buerger's disease-pos- sible role of plasminogen activator inhibitor-1 for preser- vation of vessel wall architecture[J]. Cardiovasc Pathol, 2011,20(5) :266-271.

二级参考文献3

共引文献2

同被引文献9

  • 1Douglas Hanahan,Robert A. Weinberg.Hallmarks of Cancer: The Next Generation[J].Cell.2011(5)
  • 2Christian Jorgensen,Florence Apparailly.Prospects for gene therapy in inflammatory arthritis[J].Best Practice & Research Clinical Rheumatology.2010(4)
  • 3Martine Doco-Fenzy,Emilie Landais,Joris Andrieux,Anouck Schneider,Brigitte Delemer,Véronique Sulmont,Jean-Pierre Melin,Dominique Ploton,Jessica Thevenard,Jean-Claude Monboisse,Mohamed Belouadah,Francis Lefebvre,Anne Durlach,Michel Goossens,Juliette Albuisson,Jacques Motte,Dominique Gaillard.Deletion 2q36.2q36.3 with multiple renal cysts and severe mental retardation[J].European Journal of Medical Genetics.2008(6)
  • 4Yoon Park,Sungjoo Kim Yoon,Jong-Bok Yoon.TRIP12 functions as an E3 ubiquitin ligase of APP-BP1[J].Biochemical and Biophysical Research Communications.2008(2)
  • 5Robert Visse,Hideaki Nagase.Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry[J].Circulation Research: Journal of the American Heart Association.2003(8)
  • 6Douglas Hanahan,Robert A Weinberg.The Hallmarks of Cancer[J].Cell.2000(1)
  • 7褚波,黄雪峰,唐云明.慢病毒载体及其应用进展[J].生物医学工程学杂志,2008,25(1):224-226. 被引量:22
  • 8张娇,陈爱平,戚玉言,王斌.靶向EGFR的干扰RNA对卵巢癌耐药细胞凋亡的影响[J].中国肿瘤生物治疗杂志,2009,16(6):619-623. 被引量:5
  • 9许淑芬,刘磊,方艳秋,刘多,倪志强,候俊杰,谭岩.RNAi技术沉默IGFBP-2基因对人乳腺癌细胞株MCF-7增殖的影响[J].中国妇幼保健,2013,28(28):4719-4721. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部